INFOS !
  • NEW ADDRESS: The management team of ERN-EYE is moving! Starting from March 19, you can find us at 1 Rue Eugène Boeckel, 67000 Strasbourg.

Accessibility and reading comfort

Text size

Light/Dark mode

Lines vertical spacing

Accessibility

More about accessibility

Trouble using our website?
Contact us

Text logo ERN-EYE Tools
CPMS REDgistry Elearning Members area
Accessibility

Pred Forte® in chronic central serous chorioretinopathy

In this page

Clinical Trial

2022-000338-41 Not recruiting
Pred Forte® in chronic central serous chorioretinopathy

Prednisolone eye drop in chronic central serous chorioretinopathy: a randomised clinical trial

Interventional

Disease

Disease type

Chorioretinopathy

Inclusion / Exclusion

Opening date

28/03/2022

Inclusion criteria :

More

Exclusion criteria :

More

Funding

Non-Commercial

ERN EYE member investigating site

HCP : Principal investigators

More